BCAT1 and cancer: The expression of the BCAA metabolic enzyme, such as the cytosolic branched-chain aminotransferase 1 (BCAT1) was reported to correlate in EC with more aggressive cancer growth and progression—it is related to tumor grade, FIGO stage and lymph node metastasis60.